How today’s MS treatment decisions impact tomorrow? CP 2

With the collaboration of Prof. E. Gulowsen Celius (Oslo University, Norway), Prof. G. Laureys (Ghent University Hospital) and Prof. D. Dive (Liege University Hospital)

Durée du cours: 150min
Deadline accréditation:

Pour suivre cette formation, vous devez avoir un compte et être connecté à celui-ci.

Pas encore de compte? Inscrivez-vous ici.

As our use of new MS drugs progresses, real-world evidence starts becoming available that usefully complements trials-derived knowledge. Beyond informing us on how to best move from one drug to another one, it can also refine our understanding of the longer-term consequences of the treatment choices we pose today and help us best tailoring drug choices to individual patient needs. To discuss these key elements, we have here a panel of experts who will complement mechanistic and trial considerations with their own extensive experiences, in order to share useable and practical advices and tips.